Assessing the US Medical Innovation System
Supports interdisciplinary research on how US medical innovation, policy, and institutions affect health outcomes, with selected papers presented at an NBER conference.
Funder: National Bureau of Economic Research
Due Dates: November 2, 2026
Funding Amounts: Travel and hotel reimbursement for up to two authors per accepted paper; additional authors may attend at own expense.
Summary: Supports research papers on how US medical innovation shapes health outcomes, with a focus on policy, institutional, and economic factors.
Key Information: Open to researchers in economics, management, law, health services, clinical research, and public health; not limited to NBER affiliates.
Description
This opportunity supports research that critically examines the US medical innovation system, particularly how innovation impacts health outcomes and how policies, institutions, and public/private actors influence the rate, direction, and distribution of medical progress. The initiative welcomes interdisciplinary work, including but not limited to economics, management, law, health services research, clinical research, and public health. Topics of interest include innovation policy, measurement of medical progress, regulation, pricing and access, historical and global perspectives, and the implications of AI for medical innovation.
Selected papers will be presented at a conference hosted by the NBER Center for Aging and Health Research, aiming to foster a network of scholars working on these issues.
